Fatal liver failure in a patient treated with Sunitinib for renal cell carcinoma

Clinical Genitourinary Cancer

Volumn 11, Issue 1, 2013, Pages 70-72

  Mermershtain, Willmosh ^a   Lazarev, Irena ^a   Shani Shrem, Noa ^a   Ariad, Samuel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Adverse reaction; Hepatotoxicity; Pulmonary arterial hypertension; Sunitinib; Tyrosine kinase

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DUTASTERIDE; FIBRINOGEN; HEPATITIS B SURFACE ANTIBODY; SUNITINIB; TAMSULOSIN; TIOTROPIUM BROMIDE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER PATIENT; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ECHOGRAPHY; FIBRINOGEN BLOOD LEVEL; FORCED EXPIRATORY VOLUME; HUMAN; KIDNEY CARCINOMA; LIVER FAILURE; LUNG EMPHYSEMA; LUNG FUNCTION; MALE; PARTIAL THROMBOPLASTIN TIME; PROSTATE HYPERTROPHY; PULMONARY HYPERTENSION; TRICUSPID VALVE REGURGITATION; WEAKNESS;

ANGIOGENESIS INHIBITORS; CARCINOMA, RENAL CELL; FATAL OUTCOME; HUMANS; INDOLES; KIDNEY NEOPLASMS; LIVER FAILURE; MALE; MIDDLE AGED; PYRROLES;

EID: 84874530505     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2012.09.005     Document Type: Article

References (16)

1. H. Izzedine, I. Buhaescu, O. Rixe Sunitinib malate Cancer Chemother Pharmacol 60 2007 357 364
2. SUTENT (sunitinib malate) [package insert] 2006 Pfizer Inc New York, NY revised 2011
3. R.J. Motzer, M.D. Michaelson, B.G. Redman Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma J Clin Oncol 24 2006 16 24
4. E.W. Mueller, M.L. Rockey, M.C. Rashkin Sunitinib-related fulminant hepatic failure: case report and review of the literature Pharmacotherapy 28 2008 1066 1070
5. A.M. Weise, C.Y. Liu, A.F. Shields Fatal liver failure in a patient on acetaminophen treated with sunitinib malate and levothyroxine Ann Pharmacother 43 2009 761 766
6. A. Taran, A. Ignatov, B. Smith Acute hepatic failure following monotherapy with sunitinib for ovarian cancer Cancer Chemother Pharmacol 63 2009 971 972
7. J. Victor, V.J. Navarro, J.R. Senior Drug-related hepatotoxicity N Engl J Med 354 2006 731 739
8. C.A. Naranjo, U. Busto, E.M. Sellers A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 1981 239 245
9. G. Danan, C. Benichou Causality assessment of adverse reactions to drugs: I A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 46 1993 1323 1330
10. R.J. Motzer, T.E. Hutson, P. Tomczak Overall survival and updated results for sunitinib compared with interferon: alfa in patients with metastatic renal cell carcinoma J Clin Oncol 27 2009 3584 3590
11. S. Faivre, E. Raymond, E. Boucher Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study Lancet Oncol 10 2009 794 800
12. A.X. Zhu, D.V. Sahani, D.G. Duda Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study J Clin Oncol 27 2009 3027 3035
13. R.E. Girgis, S.C. Mathai, J.A. Krishnan Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases J Heart Lung Transplant 24 2005 1626 1631
14. N. Dwyer, G. Jones, D. Kilpatrick Severe hepatotoxicity in a patient on bosentan upon addition of methotrexate: reversible with resumption of methotrexate without bosentan J Clin Rheumatol 15 2009 88 89
15. C. Eriksson, A. Gustavsson, T. Kronvall Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case report and review of the literature J Gastrointest Liver Dis 20 2011 77 80
16. ®) [package insert] 2006 US: Actelion Pharmaceuticals Allschwil, Switzerland revised 2011